233 related articles for article (PubMed ID: 9225005)
21. Activation and serine phosphorylation of the p56lck protein tyrosine kinase in response to antigen receptor cross-linking in B lymphocytes.
Gold MR; Chiu R; Ingham RJ; Saxton TM; van Oostveen I; Watts JD; Affolter M; Aebersold R
J Immunol; 1994 Sep; 153(6):2369-80. PubMed ID: 8077654
[TBL] [Abstract][Full Text] [Related]
22. Synthetic bryostatin analogues activate the RasGRP1 signaling pathway.
Stone JC; Stang SL; Zheng Y; Dower NA; Brenner SE; Baryza JL; Wender PA
J Med Chem; 2004 Dec; 47(26):6638-44. PubMed ID: 15588099
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells.
Pignata C; Prasad KV; Hallek M; Druker B; Rudd CE; Robertson MJ; Ritz J
Cell Immunol; 1995 Oct; 165(2):211-6. PubMed ID: 7553885
[TBL] [Abstract][Full Text] [Related]
24. Src regulates phorbol 12-myristate 13-acetate-activated PKC-induced migration via Cas/Crk/Rac1 signaling pathway in glioblastoma cells.
Nomura N; Nomura M; Sugiyama K; Hamada J
Int J Mol Med; 2007 Oct; 20(4):511-9. PubMed ID: 17786281
[TBL] [Abstract][Full Text] [Related]
25. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A; Lazo JS
Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
[TBL] [Abstract][Full Text] [Related]
26. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
27. PKC activators (phorbol ester or bryostatin) stimulate outgrowth of NGF-dependent neurites in a subline of PC12 cells.
Burry RW
J Neurosci Res; 1998 Jul; 53(2):214-22. PubMed ID: 9671978
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte activation provokes modification of a lymphocyte-specific protein tyrosine kinase (p56lck).
Marth JD; Lewis DB; Cooke MP; Mellins ED; Gearn ME; Samelson LE; Wilson CB; Miller AD; Perlmutter RM
J Immunol; 1989 Apr; 142(7):2430-7. PubMed ID: 2784463
[TBL] [Abstract][Full Text] [Related]
29. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
Yamaguchi H; Hendrickson WA
Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
[TBL] [Abstract][Full Text] [Related]
31. Phorbol ester and bryostatin differentially regulate the hydrolysis of phosphatidylethanolamine in Ha-ras- and raf-oncogene-transformed NIH 3T3 cells.
Kiss Z; Rapp UR; Pettit GR; Anderson WB
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):505-9. PubMed ID: 2049075
[TBL] [Abstract][Full Text] [Related]
32. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate.
Milne DM; McKendrick L; Jardine LJ; Deacon E; Lord JM; Meek DW
Oncogene; 1996 Jul; 13(1):205-11. PubMed ID: 8700548
[TBL] [Abstract][Full Text] [Related]
33. Delta-protein kinase C phosphorylation parallels inhibition of nerve growth factor-induced differentiation independent of changes in Trk A and MAP kinase signalling in PC12 cells.
Wooten MW; Seibenhener ML; Heikkila JE; Mischak H
Cell Signal; 1998 Apr; 10(4):265-76. PubMed ID: 9617484
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of protein kinase C-mediated CD4 down-regulation by oxidative stress in T lymphocytes.
Nakamura K; Sasada T; Sono H; Yodoi J
J Immunol; 1996 Dec; 157(12):5339-49. PubMed ID: 8955181
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a.
Kiss Z; Deli E; Shoji M; Koeffler HP; Pettit GR; Vogler WR; Kuo JF
Cancer Res; 1987 Mar; 47(5):1302-7. PubMed ID: 3469014
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts.
Szallasi Z; Smith CB; Pettit GR; Blumberg PM
J Biol Chem; 1994 Jan; 269(3):2118-24. PubMed ID: 8294465
[TBL] [Abstract][Full Text] [Related]
37. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
[TBL] [Abstract][Full Text] [Related]
38. In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity.
Berkow RL; Schlabach L; Dodson R; Benjamin WH; Pettit GR; Rustagi P; Kraft AS
Cancer Res; 1993 Jun; 53(12):2810-5. PubMed ID: 8504423
[TBL] [Abstract][Full Text] [Related]
39. Effects of the protein kinase C stimulant bryostatin 1 on the proliferation and colony formation of irradiated human T-lymphocytes.
Sung SJ; Lin PS; Schmidt-Ullrich R; Hall CE; Walters JA; McCrady C; Grant S
Int J Radiat Biol; 1994 Dec; 66(6):775-83. PubMed ID: 7814976
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the activity and phosphorylation of the lck protein in lymphoid cells.
Hurley TR; Sefton BM
Oncogene; 1989 Mar; 4(3):265-72. PubMed ID: 2468122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
